From camera lens and binoculars to comfortable seating and solar eclipse glasses, these are my top recommendations to get you ready for the total solar eclipse next year. Are you prepared for the next ...

The social network X is expected to begin displaying in user profiles whether someone may be using a VPN to obscure their location. Based on a post in October about transparency on the platform ...

How to Get Your Share of the AT&T Settlement Payouts You're eligible for a payout if your data was compromised in one or both of the two data breaches mentioned above. Emails are going out about the ...

How much you get will depend on how many people submit claims and what type of data was compromised. If your Social Security number was compromised, you'll get a Tier 1 Cash Payment. Otherwise, you'll ...

Leading tech companies are in a race to release and improve artificial intelligence (AI) products, leaving users in the United States to puzzle out how much of their personal data could be extracted ...

AT&T's $177 million settlement is for data breaches in 2019 and 2024. Claim up to $5,000 (first breach) and $2,500 (Snowflake hack), or both. File claim by Dec. 18, 2025, either online or by mail. If ...

The Eclipse Dataspace Protocol and Eclipse Dataspace Decentralised Claims Protocol facilitate data sharing, trust, and identity verification for dataspaces worldwide BRUSSELS, Dec. 02, 2025 (GLOBE ...

Elon Musk’s X has begun rolling out a new feature for user profiles that will display information about the account, including where it’s based, how many times the account has changed its username, ...

Palash has been writing about technology (and entertainment) for over a decade. His focus has been on the evolution of computing, ranging from smartphones to PC builds and everything in between. You ...

This is one of those rare times when I wish I didn't have personal experience I could bring to bear. Earlier this summer, my work laptop died -- it went from port and performance problems to getting ...

NORTH CHICAGO, Ill., Dec. 1, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced primary results from the pivotal Phase 3 ECLIPSE study, evaluating the safety, efficacy and tolerability of ...